• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 46

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Number of OCET-coordinated meetings regarding CT and ET issues with Centers in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
2Number of external meetings (hosted by CDC, NIH, industry, and sponsors) attended by OCET to communicate agency policy on CT and ET in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
3Number of meetings to discuss Pre-Emergency Use Authorization (EUA) development in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
4Number of documents reviewed for CT and ET policy development in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
5Total number of meeting requests received through MCM.gov in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
6Number of meetings FDA attends with sponsors who requested a meeting through MCM.gov in the monthOCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
7Implement MCM Initiative (MCMi)OCSOffice of Counterterrorism and Emerging ThreatsN/AN/A
8Strategic Science and Innovation PlanOCSOffice of the Chief ScientistN/AN/A
9Tuberculosis InitiativeOCSOffice of Regulatory Science and InnovationN/AN/A
10Tuberculosis Frozen Trial RepositoryOCSOffice of Regulatory Science and InnovationN/AN/A
11Neglected/Tropical Disease InitiativeOCSOffice of Regulatory Science and InnovationN/AN/A
12Modernize Toxicology TestingOCSOffice of Regulatory Science and InnovationN/AN/A
13Improving the Efficiency of Clinical TrialsOCSOffice of Regulatory Science and InnovationN/AN/A
14Health Resources and Services Administration (HRSA) Patient Safety and Clinical Pharmacy Services CollaborativeOCSOffice of Women's HealthN/AN/A
15Video NovellaOCSOffice of Women's HealthN/AN/A
16Number of OWH staff attending venues and partner activities where women’s information is provided in the monthOCSOffice of Women's HealthN/AN/A
17Total number of electronic OWH distributions in English and other foreign languages in the quarterOCSOffice of Women's HealthN/AN/A
18Total number of physical OWH distributions in English and other foreign languages in the quarterOCSOffice of Women's HealthN/AN/A
19Total number of OWH partner distributions in the quarterOCSOffice of Women's HealthN/AN/A
20Cumulative number of subscribers to OWH email lists and social media outlets at the end of the monthOCSOffice of Women's HealthN/AN/A
21Cumulative number of abstracts, posters, presentations or publications by OWH staff accepted in the monthOCSOffice of Women's HealthN/AN/A
22Commissioner’s Fellowship ProgramOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
23Modernizing ToxicologyOCSOffice of the Chief ScientistN/AN/A
24Centers of Excellence in Regulatory Science and Innovation (CERSI)OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
25Broad Agency Announcement (BAA)OCSOffice of Regulatory Science and InnovationN/AN/A
26FDA Nanotechnology Regulatory Science ProgramOCSOffice of Regulatory Science and InnovationN/AN/A
27Number of Departmental meetings in the month related to HHS Health Disparities Plan ImplementationOCSOffice of Minority HealthN/AN/A
28Number of HHS and FDA working groups impacting health literacy led or participated in during the monthOCSOffice of Minority HealthN/AN/A
29Number of Departmental meetings in the month related to ACA implementationACAOffice of Minority HealthN/AN/A
30Cumulative number of visits to new FDA minority health webpage in the monthOCSOffice of Minority HealthN/AN/A
31Number of external FDA stakeholder meetings in the monthOCSOffice of Minority HealthN/AN/A
32Strengthen FDA capacity to address minority health and health disparities across the AgencyACAOffice of Minority HealthN/AN/A
33Strengthen Regulatory Science/Health Disparities Research InitiativesACAOffice of Minority HealthN/AN/A
34Centers of Excellence in Regulatory Science and Innovation (CERSI) Established in 2014OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
35Science Looking Forward ReportOCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
36FDA Program for Extramural Regulatory Science and Innovation (PERSI)OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
37Office of the Chief Scientist Intramural Research GrantsOCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
38Women's Health Research RoadmapOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
39Encouraging Women to Utilize FDA Safe Medication Use ResourcesOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
40Minority Health and Health Disparities Research and Collaboration ProgramOCSOffice of Minority HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
41Strengthening FDA Outreach and Communication Programs to Minority Health Care Providers and PatientsOCSOffice of Minority HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
42Percentage of Commissioner's Fellows who graduated and who were retainedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
43Number of projects, presentations, and manuscripts completed by Commissioner's FellowsOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
44Number of FDA sponsored regulatory science training events, participants, and Continuing Education (CE) credits awardedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
45Number of FDA regulatory science training collaboration events, participants, and Continuing Education (CE) credits awardedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
46The Science of Sex and Gender in Human Health Modules III and IVOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.